NBP
NovaBridge BiosciencesNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
$1.29-2.27%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -19.9%
- 3 months
- -30.3%
- 1 year
- —
- Dividend
- No dividends on record
- Short interest
- 5.1% of float3.3M shares · settled Sep 30, 2026 · -12.4% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if NBP is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
11 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Insider context
Sentiment: bearish
Last trade: sell 24 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
49 filers reported a long position in NBP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| HHLR ADVISORS, LTD. | $11.7M | 6M | Unchanged |
| MORGAN STANLEY | $7.1M | 3.7M | -4.8% |
| AIHC Capital Management Ltd | $5.6M | 2.9M | +27.2% |
| Siren, L.L.C. | $3.9M | 2M | -33.2% |
| MARSHALL WACE, LLP | $2.4M | 1.2M | New |
| Candriam S.C.A. | $2.2M | 1.1M | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2M | 1M | Unchanged |
| TWO SIGMA INVESTMENTS, LP | $1.7M | 851.3K | New |
| RENAISSANCE TECHNOLOGIES LLC | $1.5M | 758.2K | +178.3% |
| BlackRock, Inc. | $1.3M | 686.2K | +9.4% |
Get the Full Analysis for NBP
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.